Mostrar el registro sencillo del ítem

dc.contributor.authorSantos, João Vasco
dc.contributor.authorPadron-Monedero, Alicia 
dc.contributor.authorBikbov, Boris
dc.contributor.authorGrad, Diana Alecsandra
dc.contributor.authorPlass, Dietrich
dc.contributor.authorMechili, Enkeleint A
dc.contributor.authorGazzelloni, Federica
dc.contributor.authorFischer, Florian
dc.contributor.authorSulo, Gerhard
dc.contributor.authorNgwa, Che Henry
dc.contributor.authorNoguer-Zambrano, Isabel
dc.contributor.authorPeñalvo, José L 
dc.contributor.authorHaagsma, Juanita A
dc.contributor.authorKissimova-Skarbek, Katarzyna
dc.contributor.authorMonasta, Lorenzo
dc.contributor.authorGhith, Nermin
dc.contributor.authorSarmiento Suárez, Rodrigo 
dc.contributor.authorHrzic, Rok
dc.contributor.authorHaneef, Romana
dc.contributor.authorO'Caoimh, Rónán
dc.contributor.authorCuschieri, Sarah
dc.contributor.authorMondello, Stefania
dc.contributor.authorKabir, Zubair
dc.contributor.authorGBD 2019 EU State of Health Collaborators
dc.contributor.authorFreitas, Alberto
dc.contributor.authorDevleesschauwer, Brecht
dc.contributor.authorNoguer, Isabel 
dc.date.accessioned2024-07-10T09:54:23Z
dc.date.available2024-07-10T09:54:23Z
dc.date.issued2024-05-22
dc.identifier.citationBMC Public Health. 2024 May 22;24(1):1374.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/20376
dc.descriptionThe datasets analysed during the current study are publicly available in the GBD 2019 Results Tool and GBD 2019 Compare repositories (https://vizhub.healthdata.org/gbd-​results/ and https://vizhub.healthdata.org/gbd-​compare, respectively).es_ES
dc.description.abstractBackground: The European Union (EU) faces many health-related challenges. Burden of diseases information and the resulting trends over time are essential for health planning. This paper reports estimates of disease burden in the EU and individual 27 EU countries in 2019, and compares them with those in 2010. Methods: We used the Global Burden of Disease 2019 study estimates and 95% uncertainty intervals for the whole EU and each country to evaluate age-standardised death, years of life lost (YLLs), years lived with disability (YLDs) and disability-adjusted life years (DALYs) rates for Level 2 causes, as well as life expectancy and healthy life expectancy (HALE). Results: In 2019, the age-standardised death and DALY rates in the EU were 465.8 deaths and 20,251.0 DALYs per 100,000 inhabitants, respectively. Between 2010 and 2019, there were significant decreases in age-standardised death and YLL rates across EU countries. However, YLD rates remained mainly unchanged. The largest decreases in age-standardised DALY rates were observed for "HIV/AIDS and sexually transmitted diseases" and "transport injuries" (each -19%). "Diabetes and kidney diseases" showed a significant increase for age-standardised DALY rates across the EU (3.5%). In addition, "mental disorders" showed an increasing age-standardised YLL rate (14.5%). Conclusions: There was a clear trend towards improvement in the overall health status of the EU but with differences between countries. EU health policymakers need to address the burden of diseases, paying specific attention to causes such as mental disorders. There are many opportunities for mutual learning among otherwise similar countries with different patterns of disease.es_ES
dc.description.sponsorshipThe authors would like to acknowledge the networking support from COST Action CA18218 (European Burden of Disease Network), supported by COST (European Cooperation in Science and Technology). This article was supported by National Funds through FCT - Fundação para a Ciência e a Tecnologia,I.P., within CINTESIS, R&D Unit (reference UIDB/4255/2020).. T W Bärnighausen was supported by the Alexander von Humboldt Foundation through the Alexander von Humboldt Professor award, funded by the German Federal Ministry of Education and Research. L Belo acknowledges the support from FCT in the scope of the project UIDP/04378/2020 and UIDB/04378/2020 of UCIBIO and the project LA/P/0140/2020 of i4HB. D A Bennett is supported by the UK Medical Research Council Population Health Research Unit at the University of Oxford. M Carvalho acknowledges the support from FCT in the scope of the project UIDP/04378/2020 and UIDB/04378/2020 of UCIBIO and the project LA/P/0140/2020 of i4HB. A L Catapano is supported in part by the Ministero della Salute ricerca corrente. J S Chandan acknowledges the National Institute of Health Research. J Conde would like to acknowledge the European Research Council Starting Grant (ERC-StG-2019–848325). D Dias da Silva acknowledges the projects UIDP/04378/2022 and UIDB/04378/2022 of the Research Unit on Applied Molecular Biosciences UCIBIO; the project LA/P/0140/2022 of the Associate Laboratory Institute for Health and i4HB; and IINFACTS-Institute of Research and Advanced Training in Health Sciences and Technologies (project PsiloPharm) and TOXRUN Toxicology Research Unit, University Institute of Health Sciences, IUCS-CESPU, Portugal. A Douiri acknowledges support by King’s Health Partners/Guy’s and St Thomas Charity “MLTC Challenge Fund” (grant number EIC180702) and the NIHR Applied Research Collaboration (ARC) South London at King’s College Hospital NHS Foundation Trust. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. J C Fernandes acknowledges support from Fundação para a Ciência e Tecnologia (FCT) with funding for UID/Multi/50016/2019. G Gazzard acknowledges support from NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, London, UK and Institute of Ophthalmology, University College London, UK. P S Gill acknowledges being NIHR senior investigator for the NIHR Department of Health and Social Care. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. J C Glasbey is supported by a UK National Institute of Health Research Doctoral Research Fellowship (NIHR300175). S Hussain was supported from Operational Programme Research, Development and Education “Project, Postdoc2MUNI” (No.CZ.02.2.6 9/0.0/0.0/18_053/0016952). M AB Khan acknowledges support as recipient of research grants G00003634- CMHS “NP-22–20 80, 000 AED (2021), G00003569 NP-21–13 80,000 AED, and 1976—SDG Research Program Grant 40,000 AED. B Lacey acknowledges support from UK Biobank, which is funded largely by the UK Medical Research Council and Wellcome. J A Loureiro was supported by National Funds through Fundação para a Ciência e Tecnologia (FCT) under the Scientific Employment Stimulus’ Institutional Call—[CEECINST/00049/2018]. S Lorkowski acknowledges institutional support from the Competence Cluster for Nutrition and Cardiovascular Health (nutriCARD) Halle-Jena-Leipzig (Germany; German Federal Ministry of Education and Research; grant agreement number 01EA1808A). A G Mathioudakis acknowledges support by the National Institute for Health and Care Research Manchester Biomedical Research Centre (NIHR Manchester BRC) and by an NIHR Clinical Lectureship in Respiratory Medicine. J J McGrath was supported by the Danish National Research Foundation (Niels Bohr Professorship) and is employed by The Queensland Centre for Mental Health Research, which receives core funding from the Queensland Health. S Mohammed reports fellowship grant from Alexander von Humboldt Foundation, outside the submitted work. L Monasta received support from the Italian Ministry of Health, through the contribution given to the Institute for Maternal and Child Health IRCCS Burlo Garofolo, Trieste, Italy (RC 34/2017). P Pedersini was supported and funded by the Italian Ministry of Health—Ricerca Corrente 2021. M Pinheiro thanks FCT for funding through program DL 57/2016 Norma transita. A Raggi acknowledges support by the Italian Ministry of Health (RRC). A Riad was supported by the project of the Ministry of Education, Youth and Sports of the Czech Republic (Systemic Risk Institute "SYRI": LX22NPO5101) and the projects of Masaryk University (MUNI/A/1402/2021 and MUNI/IGA/1104/2021). S T Skou is currently funded by a grant from Region Zealand (Exercise First) and two grants from the European Union’s Horizon 2020 Research and Innovation Program, one from the European Research Council (MOBILIZE, grant agreement No 801790) and the other under grant agreement No 945377 (ESCAPE). J B Soriano is supported by Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias, Instituto de Salud Carlos III, Madrid, Spain. L Stockfelt was funded by the Swedish state under the agreement between the Swedish government and the country councils, the ALF-agreement. Johan Sundström acknowledges stock ownership in Anagram kommunikation AB and Symptoms Europe AB. R Tabares-Seisdedos is supported by the Spanish Ministry of Science and Innovation, Institute of Health Carlos III, CIBERSAM, INCLIVA (PID2021-129099OB-I00). M R Tovani-Palone acknowledges Saveetha Institute of Medical and Technical Sciences (SIMATS) for its support. J H Villafañe was supported and funded by the Italian Ministry of Health—Ricerca Corrente 2021. A Zumla acknowledges grant support from the Pan-African Network for Rapid Research, Response, Relief and Preparedness for Infectious Diseases Epidemics (PANDORA-ID-NET) ONE-HEALTH (Europe-Africa) consortium funded by the European and Developing Countries Clinical Trials Partnership, which is supported by Horizon 2020, the EU’s Framework Programme for Research and Innovation.es_ES
dc.language.isoenges_ES
dc.publisherBioMed Central (BMC) es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectEuropean Uniones_ES
dc.subjectHealth statuses_ES
dc.subjectPopulation healthes_ES
dc.subjectGlobal Burden of Diseaseses_ES
dc.subjectEuropean Burden of Disease Networkes_ES
dc.subject.meshEuropean Union es_ES
dc.subject.meshGlobal Burden of Disease es_ES
dc.subject.meshLife Expectancy es_ES
dc.subject.meshDisability-Adjusted Life Yearses_ES
dc.subject.meshHumans es_ES
dc.subject.meshMale es_ES
dc.subject.meshHealth Status es_ES
dc.subject.meshFemale es_ES
dc.subject.meshCost of Illness es_ES
dc.titleThe state of health in the European Union (EU-27) in 2019: a systematic analysis for the Global Burden of Disease study 2019es_ES
dc.typeresearch articlees_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.identifier.pubmedID38778362es_ES
dc.format.volume24es_ES
dc.format.number1es_ES
dc.format.page1374es_ES
dc.identifier.doi10.1186/s12889-024-18529-3es_ES
dc.contributor.funderUnión Europea. European Cooperation in Science and Technology (COST) es_ES
dc.contributor.funderAlexander von Humboldt Foundation es_ES
dc.contributor.funderFederal Ministry of Education & Research (Alemania) es_ES
dc.contributor.funderFundação para a Ciência e Tecnologia (Portugal) es_ES
dc.contributor.funderMinistero della Salute (Italia) es_ES
dc.contributor.funderMedical Research Council (Reino Unido) es_ES
dc.contributor.funderUniversity of Oxford (Reino Unido) es_ES
dc.contributor.funderInstituto de Salud Carlos III es_ES
dc.contributor.funderUnión Europea. Comisión Europea. H2020 es_ES
dc.contributor.funderNational Institute for Health Research (Reino Unido) es_ES
dc.contributor.funderNHS - Foundation Trust es_ES
dc.contributor.funderUniversity College London Hospitals NHS Foundation Trust es_ES
dc.contributor.funderUnión Europea. Comisión Europea. European Research Council (ERC) es_ES
dc.contributor.funderUnidade em Ciências Biomoleculares Aplicadas (UCIBIO) (Portugal)es_ES
dc.contributor.funderUniversity Institute of Health Sciences (IUCS-CESPU) (Portugal)es_ES
dc.contributor.funderNIHR - Manchester Biomedical Research Centre (Reino Unido)es_ES
dc.contributor.funderDanish National Research Foundation es_ES
dc.contributor.funderQueensland Centre for Mental Health Research (Australia)es_ES
dc.contributor.funderMinistry of Education, Youth and Sports (República Checa) es_ES
dc.contributor.funderSIMATS Deemed University (India)es_ES
dc.contributor.funderFondazione IRCCS. Materno Infantile Burlo Garofolo es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn1471-2458es_ES
dc.relation.publisherversionhttps://doi.org/10.1186/s12889-024-18529-3es_ES
dc.identifier.journalBMC public healthes_ES
dc.repisalud.centroISCIII::Escuela Nacional de Sanidades_ES
dc.repisalud.centroISCIII::Centro Nacional de Epidemiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/945377/EUes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/ERC-StG-2019–848325es_ES
dc.rights.accessRightsopen accesses_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PID2021-129099OB-I00es_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail
Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución 4.0 Internacional